Business Context and Reporting Period
This Form 8-K Current Report, dated September 30, 2025, details significant capital structure updates for Omega Healthcare Investors, Inc. (OHI). The filing focuses on the entry into a new senior unsecured credit facility and the amendment of an existing term loan agreement to optimize borrowing costs and extend maturity profiles.
Key Financial Metrics and Capital Structure
- New Credit Facility: Established a $2.3 billion senior unsecured facility consisting of a $2.0 billion multicurrency revolving credit facility and a $300.0 million delayed draw term loan (DDTL).
- Existing Term Loan: As of September 30, 2025, OHI had $428.5 million in borrowings outstanding under its existing Term Loan Credit Agreement.
- Utilization: No borrowings were outstanding under the new Credit Facility as of the filing date.
- Interest Margins (Revolving): Ranges from 0.725% to 1.40% (Eurocurrency/SOFR) and 0% to 0.40% (Base Rate), dependent on credit ratings.
- Interest Margins (DDTL): Ranges from 0.800% to 1.60% (SOFR) and 0% to 0.60% (Base Rate).
- Amended Term Loan Margins: Reduced to a range of 0.800% to 1.60% (SOFR) and 0% to 0.60% (Base Rate).
Material Changes Versus Prior Period
- Facility Replacement: The new $2.3 billion facility replaces the previous $1.45 billion senior unsecured revolving credit facility (2021 Revolving Credit Facility), which was scheduled to expire on October 30, 2025.
- Termination: The 2021 Revolving Credit Facility was terminated without material early termination penalties.
- Cost Reduction: The First Amendment to the Term Loan Credit Agreement reduced interest rate margins and removed the 0.100% interest rate step-up for each extension period.
- Maturity Extension: The new Revolving Credit Facility matures on September 28, 2029 (with two 6-month extension options), and the DDTL matures on September 29, 2028 (with two 12-month extension options).
Outlook, Management Commentary, and Risks
- Use of Proceeds: Funds may be used to refinance existing indebtedness, finance general corporate working capital, acquisitions of healthcare-related properties, capital expenditures, or other general corporate purposes.
- Flexibility: The agreement includes an accordion feature allowing OHI to increase aggregate commitments to $3.0 billion subject to customary conditions.
- Covenants: The agreement includes standard affirmative and negative covenants, including maximum total leverage, minimum fixed charge coverage, and minimum consolidated tangible net worth.
- Fees: A "ticking fee" of 0.25% per annum will accrue on the undrawn DDTL commitments starting December 29, 2025.
- Risks: The filing notes that lenders and their affiliates may engage in future transactions with OHI in the ordinary course of business.
Investor Verification Checklist
- Verify the specific credit rating of OHI to determine the exact applicable interest margin within the disclosed ranges.
- Confirm the status of the $428.5 million outstanding term loan and its impact on total leverage ratios.
- Review the full text of the Amended and Restated Credit Agreement (Exhibit 10.1) for detailed covenant definitions and default triggers.
- Monitor the utilization of the $300 million DDTL facility, as the ticking fee applies to undrawn amounts after December 29, 2025.
- Assess the strategic intent behind the facility expansion from $1.45 billion to $2.3 billion in the context of OHI's acquisition pipeline.